Neuros Medical Inc has secured $20m in a series AA Financing round led by US Venture Partners.

The US-based company plans to use the funds to progress its IDE clinical study.

Evolent Health Inc has announced a public offering of seven million class A common stock shares priced at $24.1 each to raise $175m.

"Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products."

Located in the US, Evolent plans to use funds to purchase class A common shares.

US-based company Osprey Medical Inc has announced the private placement of 27 million common stock shares priced at A$0.4 ($0.32) each to raise A$22.18m ($17.61m).

Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData